Effect of Selective Serotonin Reuptake Inhibitors on Platelet Activation

@article{Schlienger2003EffectOS,
  title={Effect of Selective Serotonin Reuptake Inhibitors on Platelet Activation},
  author={Raymond Schlienger and Christoph R. Meier},
  journal={American Journal of Cardiovascular Drugs},
  year={2003},
  volume={3},
  pages={149-162}
}
  • R. Schlienger, C. Meier
  • Published 2003
  • Biology, Psychology, Medicine
  • American Journal of Cardiovascular Drugs
In recent years a large body of evidence from several longitudinal studies has emerged suggesting that depression is an independent risk factor for cardiovascular disease (CVD) and that the association between depression and increased CVD risk is not merely due to negative mood-driven behavior related with depression. Even though the underlying mechanisms are not well understood, several hypotheses and explanations have been proposed such as increased activation of the hypothalamic-pituitary… 
Current Use of Selective Serotonin Reuptake Inhibitors and Risk of Acute Myocardial Infarction
TLDR
Evidence is provided that the current use of SSRIs is associated with a slightly decreased risk for AMI, and the influence of timing of the exposure to antidepressants in a general adult population, with or without diagnosed risk factors, is assessed.
Serotonergic mechanisms enhance platelet-mediated thrombogenicity.
TLDR
5-HT is not a weak agonist for human platelets; instead it accentuates platelet activation, potentiates procoagulant responses on human blood and increases thrombogenesis on damaged vascular surfaces.
The contribution of platelet studies to the understanding of disease mechanisms in complex and monogenetic neurological disorders
TLDR
A literature update on the use of platelets as easily accessible cells to study neurological disorders is provided and examples of theuse of different platelet‐based tests to understand the underlying pathophysiological mechanisms for both complex and monogenetic neuropathological disorders are provided.
Pharmacometabolomics Reveals That Serotonin Is Implicated in Aspirin Response Variability
TLDR
Results suggest that serotonin is implicated in aspirin response variability, and ex vivo, serotonin strongly increased platelet reactivity after platelet incubation with aspirin.
Venous thromboembolism and escitalopram.
5‐HYDROXYTRYPTAMINE IN THE CARDIOVASCULAR SYSTEM: FOCUS ON THE SEROTONIN TRANSPORTER (SERT)
  • W. Ni, S. Watts
  • Biology
    Clinical and experimental pharmacology & physiology
  • 2006
TLDR
The function of SERT in the CV system is just beginning to be revealed, but includes modulation of cardiac and smooth muscle contractility, platelet aggregation, cellular mitogenesis, modulating neuronal activity and urinary excretion.
Degree of serotonin reuptake inhibition of antidepressants and ischemic risk
TLDR
A large population-based study suggests that antidepressants strongly inhibiting serotonin reuptake may be associated with a small decrease in the rate of ischemic stroke.
Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression
TLDR
Untreated depressed patients showed increased plasmaBDNF levels and decreased platelet BDNF levels, as compared with control subjects, and tend to normalize during treatment with S-citalopram for 24 weeks, with BDNF reaching levels similar to those in healthy controls at the 24th week in both samples.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 115 REFERENCES
Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors.
TLDR
Both sertraline, and its neurologically inactive metabolite NDMS, exhibited significant dose-dependent inhibition of human platelets, directly related to the mortality benefits of SSRIs after ischemic events including myocardial infarction and stroke.
Increased platelet aggregability in major depression?
Abnormal Platelet Aggregation Associated with Fluoxetine Therapy
TLDR
The rapid normalization of platelet aggregation after the withdrawal of fluoxetine in this patient does not conform to the known clinical pharmacokinetics of norfluoxetines, suggesting that the parent drug was the causative agent.
Role of catecholamines in platelet function: pathophysiological and clinical significance
TLDR
The modulation of platelet function by the sympathoadrenal system is examined and the role of circulating catecholamines in the control of platelets responses is concentrated on.
Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction.
TLDR
Evidence is provided that SSRI exposure does not substantially decrease the risk of developing first-time AMI in patients free of factors predisposing to ischaemic heart disease, however, due to relatively small numbers of exposed subjects and the resulting wide confidence intervals, further studies may be needed to document a lack of effect of SSRIs in subjects without pre-existing diseases predispose to AMI.
Platelets and coronary heart disease: potential psychophysiologic mechanisms.
TLDR
The literature to date supports the hypothesis that platelet activity is increased by emotional stress, and it is proposed that platelets reactivity to psychological stress may be a major mechanism in coronary events.
Exaggerated platelet reactivity in major depression.
TLDR
Depressed patients exhibit enhanced baseline platelet activation and responsiveness in comparison with normal subjects, which may be a mechanism by which depression is a significant risk factor for ischemic heart and cerebrovascular disease and/or mortality after myocardial infarction.
Clinical overview of serotonin reuptake inhibitors.
TLDR
Serotonin reuptake inhibitors have not replaced the tricyclics, but are a useful addition to the variety of drugs currently used for the treatment of depression.
Serotonin and Fluoxetine Levels in Plasma and Platelets After Fluoxetine Treatment in Depressive Patients
TLDR
Plasma fluoxetine and serotonin levels increased after drug administration, reaching the highest levels on the 30th day of fluoxettine 20 mg, and platelets serotonin levels decreased, with a time variation similar to plasma values.
Selective Serotonin Reuptake Inhibitors and Myocardial Infarction
TLDR
The use of SSRIs may confer a protective effect against MI, which could be attributable to the inhibitory effectSSRIs have on serotonin-mediated platelet activation or possibly amelioration of other factors associated with increased risk for MI in depression.
...
1
2
3
4
5
...